Literature DB >> 27553919

Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update.

Erica Simon1, Brit Long1, Alex Koyfman2.   

Abstract

BACKGROUND: Sickle cell disease (SCD) affects approximately 100,000 individuals in the United States. Due to alterations in the structural conformation of hemoglobin molecules under deoxygenated conditions, patients with SCD are predisposed to numerous sequelae, many of which require acute intervention.
OBJECTIVE: Our aim was to provide emergency physicians with an evidence-based update regarding the diagnosis and management of SCD complications. DISCUSSION: SCD patients experience significant morbidity and mortality secondary to cerebrovascular accident, acute chest syndrome, acute vaso-occlusive pain crises, SCD-related multi-organ failure, cholecystitis, acute intrahepatic cholestasis, acute sickle hepatic crisis, acute hepatic sequestration, priapism, and renal disease. Emergency physicians must recognize acute manifestations of SCD in order to deliver timely management and determine patient disposition.
CONCLUSIONS: A comprehensive review of the emergency department management of acute SCD complications is provided. Comprehensive understanding of these aspects of SCD can assist physicians in expediting patient evaluation and treatment, thus decreasing the morbidity and mortality associated with this hemoglobinopathy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute chest; acute pain crisis; cerebrovascular accident; sickle cell disease; transfusion

Mesh:

Year:  2016        PMID: 27553919     DOI: 10.1016/j.jemermed.2016.05.042

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  11 in total

Review 1.  Interventions for treating intrahepatic cholestasis in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 2.  Imaging review of sickle cell disease for the emergency radiologist.

Authors:  Shenise N Gilyard; Scott L Hamlin; Jamlik-Omari Johnson; Keith D Herr
Journal:  Emerg Radiol       Date:  2020-07-31

3.  Pediatric Acute Liver Failure in Sickle Cell Disease.

Authors:  Luís Rodrigues; Sofia Almeida; Catarina Salgado; Cristina Gonçalves
Journal:  GE Port J Gastroenterol       Date:  2021-04-28

4.  Emergency Department Provider Survey Regarding Acute Sickle Cell Pain Management.

Authors:  Olufunke Y Martin; Sean M Thompson; Aaron E Carroll; Seethal A Jacob
Journal:  J Pediatr Hematol Oncol       Date:  2020-08       Impact factor: 1.170

5.  Interventions for treating intrahepatic cholestasis in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-06-22

6.  A prospective study of the association between sickle cell disease and hepatobiliary effects in Bahrain.

Authors:  Maheeba A M Abdulla; Fajer Juma Almoosa; Rana Juma Almoosa; Jehad Al Qamish
Journal:  Int J Gen Med       Date:  2017-08-04

7.  The impact of sickle cell anemia on the quality of life of sicklers at school age.

Authors:  Karimeldin M A Salih
Journal:  J Family Med Prim Care       Date:  2019-02

8.  Radiological Patterns in Sickle Cell Disease Patients with Acute Chest Syndrome: Are There Age-Related Differences?

Authors:  Abdulaziz Mohammad Al-Sharydah; Mohammed Alshahrani; Bander Aldhaferi; Afnan Fahad Al-Muhanna; Hanadi Al-Thani
Journal:  Saudi J Med Med Sci       Date:  2019-04-12

9.  Asymptomatic Hepatic Sequestration with Extreme Hyperbilirubinemia in an Adult Homozygous Sickle Cell Patient.

Authors:  Syed Musa Raza; Mehdi Faraji; Omar Khan; Rimsha Shaukat
Journal:  Cureus       Date:  2020-03-08

10.  Critical Care Education Day: A Novel, Multidisciplinary, and Interactive Critical Care Education Session for Emergency Medicine Residents.

Authors:  Natalie N Htet; Alexandra June Gordon; Tsuyoshi Mitarai
Journal:  Cureus       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.